| Old Articles: <Older 3341-3350 Newer> |
|---|
 |
Chemistry World
June 26, 2014
Rebecca Trager |
UCLA chemist avoids prison time for lethal lab accident Russ Phifer, executive director of the National Registry of Certified Chemists thinks the charges brought against Patrick Harran and UCLA have improved lab safety.   |
AFP eWire
June 24, 2014 |
Canada's Anti-Spam Legislation (CASL) Charities have been concerned that some of their activities that generate significant funds for the organization would not be exempt from CASL or Canada's Anti-Spam Legislation2. |
Information Today
June 24, 2014
George H. Pike |
First Sale Hearing Raises Questions on Kirtsaeng and Digital Goods A congressional hearing on the future of the first sale doctrine produced great discussion but little consensus on whether Congress should modify the doctrine in response to the Supreme Court's decision. |
Information Today
June 19, 2014 |
Court of Appeals Keeps Sherlock Holmes in the Public Domain The Seventh U.S. Circuit Court of Appeals upheld the ruling that the characters in the Sherlock Holmes series created by Sir Arthur Conan Doyle are in the public domain. |
National Defense
July 2014
Stew Magnuson |
Launch Contract Dispute Pits SpaceX Against Air Force, ULA A dispute between rocket-builder SpaceX and the Air Force over launch contracts came to the fore when the company's founder, Elon Musk announced a lawsuit directed at the service. |
Chemistry World
June 10, 2014
Rebecca Trager |
Attempted poisoning wasn't chemical warfare, court rules The US supreme court has quashed the conviction of a microbiologist jailed on chemical terrorism charges by weighing in on a bizarre love triangle. |
Chemistry World
June 10, 2014
Anthony King |
Drug giants settle mismarketing lawsuits Pfizer and GlaxoSmithKline recently agreed to separate settlements over allegations of mismarketing drugs in the US. |
Pharmaceutical Executive
June 1, 2014
dos Santos & Leskin |
Social Media and the In-House Counsel Social media poses a regulatory and litigation maze that must be carefully navigated by pharmaceutical companies. |
CIO
May 27, 2014
Adam Ruttenberg |
Who Legally Owns Your Big Data? Commingling internal and external data can produce problems if your contract isn't clear about who owns what -- and for how long. |
Chemistry World
May 29, 2014
Phillip Broadwith |
Boehringer to settle blood thinner drug suits for $650m Boehringer-Ingelheim has committed $650 million to settle around 4000 US court cases relating to its anticoagulant stroke prevention drug Pradaxa (dabigatran). |
| <Older 3341-3350 Newer> Return to current articles. |
